Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- United States of America
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Cognitive impairment Abnormality of cognition,Cognitive abnormality,Cognitive defects,Cognitive deficits,Cognitive impairment,Intellectual impairment,cognitive impairment
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Cognitive Normal
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Mild Cognitive Impairment
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Participants diagnosed with early Mild Cognitive Impairment (diagnosed using ADNI-2 criteria) randomly assigned to either a modified Mediterranean-ketogenic diet (MMKD) or an American heart association diet (AHAD) group
- Group 0 sample size Number of subjects in the control (unexposed) group
- 6
- Group 1 sample size Number of subjects in the case (exposed) group
- 11
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- None
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- LEfSe
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig. 1d-n and Result text
Description: Differences in the gut microbiome between subjects clinically diagnosed with mild cognitive impairment (MCI) versus cognitively normal (CN) counterparts.
Abundance in Group 1: increased abundance in Mild Cognitive Impairment
NCBI | Quality Control | Links |
---|---|---|
Coprococcus | ||
Enterobacteriaceae | ||
Phascolarctobacterium | ||
Pseudomonadota | ||
MogibacteriaceaeMogibacteriaceae |
Revision editor(s): MyleeeA, Welile, Scholastica
Signature 2
Source: Fig. 1d-n and Result text
Description: Differences in the gut microbiome between subjects clinically diagnosed with mild cognitive impairment (MCI) versus cognitively normal (CN) counterparts.
Abundance in Group 1: decreased abundance in Mild Cognitive Impairment
NCBI | Quality Control | Links |
---|---|---|
Dialister |
Revision editor(s): MyleeeA, Scholastica
Experiment 2
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Post American heart association diet (AHAD) in MCI
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Post modified Mediterranean-ketogenic diet (MMKD) in MCI
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Participants diagnosed with early mild cognitive impairment (MCI) at endpoint of the modified Mediterranean-ketogenic diet (MMKD) intervention
- Group 0 sample size Number of subjects in the control (unexposed) group
- 11
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig. 4 and Text
Description: Significant bacterial taxa at endpoint American heart association diet (Post-AHAD) intervention compared to endpoint modified Mediterranean-ketogenic diet (Post-MMKD) intervention
Abundance in Group 1: decreased abundance in Post modified Mediterranean-ketogenic diet (MMKD) in MCI
NCBI | Quality Control | Links |
---|---|---|
Bifidobacteriaceae | ||
Bifidobacterium |
Revision editor(s): MyleeeA, Scholastica
Experiment 3
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Post American heart association diet (AHAD) in CN and MCI
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Post modified Mediterranean-ketogenic diet (MMKD) in CN and MCI
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- All Participants including cognitively normal (CN) and those diagnosed with early mild cognitive impairment (MCI) at endpoint of the modified Mediterranean-ketogenic diet (MMKD) intervention
- Group 0 sample size Number of subjects in the control (unexposed) group
- 17
- Group 1 sample size Number of subjects in the case (exposed) group
- 17
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Fig. 4
Description: Significant bacterial taxa at endpoint American heart association diet (Post-AHAD) intervention compared to endpoint modified Mediterranean-ketogenic diet (Post-MMKD) intervention
Abundance in Group 1: decreased abundance in Post modified Mediterranean-ketogenic diet (MMKD) in CN and MCI
NCBI | Quality Control | Links |
---|---|---|
Bifidobacteriaceae | ||
Bifidobacterium |
Revision editor(s): MyleeeA, Scholastica
Experiment 4
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Pre modified Mediterranean-ketogenic diet (MMKD) in CN and MCI
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Richness Number of species
- unchanged
- Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
- unchanged
Signature 1
Source: Suppl. Fig.4.
Description: Lefse analysis showing bacterial taxa contributing to the microbiome difference at baseline (pre) compared to endpoint (post) modified Mediterranean-ketogenic diet (MMKD)
Abundance in Group 1: increased abundance in Post modified Mediterranean-ketogenic diet (MMKD) in CN and MCI
NCBI | Quality Control | Links |
---|---|---|
Lactococcus |
Revision editor(s): MyleeeA, Scholastica
Signature 2
Source: Suppl. Fig.4.
Description: Lefse analysis showing bacterial taxa contributing to the microbiome difference at baseline (pre) compared to endpoint (post) modified Mediterranean-ketogenic diet (MMKD)
Abundance in Group 1: decreased abundance in Post modified Mediterranean-ketogenic diet (MMKD) in CN and MCI
NCBI | Quality Control | Links |
---|---|---|
Actinomycetota | ||
Bifidobacteriaceae | ||
Bifidobacteriales | ||
Bifidobacterium |
Revision editor(s): Scholastica